Pro Share Advisors LLC Tyme Technologies, Inc. Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$1.14 - $1.87 $21,160 - $34,710	-18,562 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.34 - $3.53 $4,254 - $11,207	3,175 Added 20.63%	18,562 $33,000
Q4 2020 Feb 09, 2021	BUY	$0.87 - $1.26 $13,386 - $19,387	15,387 New	15,387 $19,000
Q3 2019 Nov 12, 2019	SELL	$0.97 - $1.77 $10,691 - $19,508	-11,022 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$0.96 - $1.89 $271 - $534	-283 Reduced 2.5%	11,022 $13,000
Q1 2019 May 15, 2019	BUY	$1.76 - $3.73 $616 - $1,305	350 Added 3.19%	11,305 $20,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.21 $22,019 - $46,120	10,955 New	10,955 $40,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.